Immunopathogenesis of recurrent vulvovaginal candidiasis.
about
Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicansSpt3 plays opposite roles in filamentous growth in Saccharomyces cerevisiae and Candida albicans and is required for C. albicans virulence.An investigation into the pathogenesis of vulvo-vaginal candidosisA pre-therapeutic coating for medical devices that prevents the attachment of Candida albicans.Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.Animal models for candidiasisEvaluation of the Oricult-N dipslide for laboratory diagnosis of vaginal candidiasis.Th17 cells and IL-17 in protective immunity to vaginal candidiasis.Serologic response to cell wall mannoproteins and proteins of Candida albicansAnalysis of vaginal cell populations during experimental vaginal candidiasis.Local production of chemokines during experimental vaginal candidiasisEffects of reproductive hormones on experimental vaginal candidiasis.Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicansCell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis.Vaginal epithelial cell anti-Candida albicans activity is associated with protection against symptomatic vaginal candidiasis.Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasisImmune cell-mediated protection against vaginal candidiasis: evidence for a major role of vaginal CD4(+) T cells and possible participation of other local lymphocyte effectors.Candida-specific antibodies during experimental vaginal candidiasis in mice.Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasisSmall but crucial: the novel small heat shock protein Hsp21 mediates stress adaptation and virulence in Candida albicans.Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis.The synthetic melanocortin (CKPV)2 exerts anti-fungal and anti-inflammatory effects against Candida albicans vaginitis via inducing macrophage M2 polarization.The acute neutrophil response mediated by S100 alarmins during vaginal Candida infections is independent of the Th17-pathway.TUP1, CPH1 and EFG1 make independent contributions to filamentation in candida albicans.Role for dendritic cells in immunoregulation during experimental vaginal candidiasisProspects for development of a vaccine to prevent and control vaginal candidiasis.CX3CR1 is dispensable for control of mucosal Candida albicans infections in mice and humans.Candida albicans adhesion to and invasion and damage of vaginal epithelial cells: stage-specific inhibition by clotrimazole and bifonazole.Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats.Influence of ovarian hormones on urogenital infection.What to do with the patient with recurrent vulvovaginal candidiasis.Genital allergy.A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response.Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.Protocols for vaginal inoculation and sample collection in the experimental mouse model of Candida vaginitisAnticandidal immunity and vaginitis: novel opportunities for immune intervention.Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection.A Candida albicans mannoprotein deprived of its mannan moiety is efficiently taken up and processed by human dendritic cells and induces T-cell activation without stimulating proinflammatory cytokine productionChemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis.Cervical mucins carry alpha(1,2)fucosylated glycans that partly protect from experimental vaginal candidiasis.
P2860
Q24550731-8D9C179E-C5B8-4FC8-B73E-0D5CF2BB789EQ27938611-105C422F-7738-46D1-9F94-F476A2FF4A56Q28366704-33FD8E2F-EB15-4427-9BC8-C241B0C9486DQ33709290-4BC9ED66-AD3E-4174-9F16-B5BDBE99DBB4Q33859133-EACF66E9-2E39-4671-96B4-428ED59059E9Q33870482-DE9A99B0-09D9-43E4-A9F2-B44F62B4651DQ33965975-F24D1E62-0FB8-48ED-84ED-820A8A8B59F0Q33983438-262BF22C-BFE4-47D1-ABDE-CDABFDEA712AQ33992594-301D3D8C-694A-4231-9B5A-578740F90E42Q34001275-FA49B112-ABED-4B6E-87F9-15329CFDE510Q34002426-DCAF14CD-56F9-4C2B-ADC9-88864A3BBB72Q34003240-9C55EBD3-3842-46BB-A62E-642016DCABE3Q34004652-9D8CD240-2DFD-472A-A6E9-C99E9F391279Q34008683-0C7C1515-C534-48FC-8734-3D120D299521Q34111909-0823F104-AB12-434C-A8BD-1ED03335231EQ34121150-8E0DE3EF-AEDD-4760-BBA0-12ADCB267009Q34130381-DD926398-0C8F-4A49-938F-CC88B128A7EDQ34131799-EA2FCADB-3584-4939-B2A0-A5557B614C7FQ34229783-DA763E79-3933-4164-929C-7BCB3966FA05Q34299685-5AA8012D-16C7-4EBF-AE34-8328AA153DAAQ34309699-2A1AEFAF-B8F2-4B18-AD75-89C4A2FA7F72Q34330822-26FD8584-D271-4224-9C70-E308DD039ED3Q34438747-C427EE32-EACE-4158-A7E5-E550E7431F53Q34609405-88F40F38-1B35-4F15-BA73-2A067E8C98A8Q34681008-D07CEE0E-9B61-45B2-9C7F-9B51A81E6474Q34707478-1710D357-D99B-4618-BEE3-571BD9F5D0C9Q35098244-FD4C3EF9-5A44-42FD-8A9A-7C5FA7A34CE7Q35191435-127BFBBC-B935-4799-85D6-79C2F9185F1FQ35553521-B6099E09-146A-4A25-AD5C-D99E995871A2Q35562045-EC64949C-EC8B-4ABE-ADD1-F91B765E3C49Q35562545-613E07C2-03C3-4611-8CAA-FA94F77184C0Q35563071-329BF197-49F2-4F32-AF90-6016BF1F759DQ35903282-8E57F74E-80C6-4CC5-8131-D2304542AB10Q35920633-EBA6B96A-76C2-486F-9053-32E74EC1A00BQ36015132-67FA5603-1614-44B3-8EE6-A0E10CCE7C97Q36097307-8ACF3337-04EE-4DE4-8E76-A27A61C06BCFQ36539905-E62F0751-EA05-4953-A7B2-031DFCCE7865Q36845263-8E34E252-AB82-49B1-B55A-ED574298D7D4Q37104113-36AF59B7-9605-45BA-B9FE-3E3C57256BBAQ37479984-6839CFC1-DA6A-4FAC-8C73-30230D41FB9E
P2860
Immunopathogenesis of recurrent vulvovaginal candidiasis.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Immunopathogenesis of recurrent vulvovaginal candidiasis.
@ast
Immunopathogenesis of recurrent vulvovaginal candidiasis.
@en
Immunopathogenesis of recurrent vulvovaginal candidiasis.
@nl
type
label
Immunopathogenesis of recurrent vulvovaginal candidiasis.
@ast
Immunopathogenesis of recurrent vulvovaginal candidiasis.
@en
Immunopathogenesis of recurrent vulvovaginal candidiasis.
@nl
prefLabel
Immunopathogenesis of recurrent vulvovaginal candidiasis.
@ast
Immunopathogenesis of recurrent vulvovaginal candidiasis.
@en
Immunopathogenesis of recurrent vulvovaginal candidiasis.
@nl
P2860
P356
P1476
Immunopathogenesis of recurrent vulvovaginal candidiasis
@en
P2093
P2860
P304
P356
10.1128/CMR.9.3.335
P407
P577
1996-07-01T00:00:00Z